Viewing Opinion | StockChase
stockchase picture

Compiling comments that experts make about stocks while on public TV.

2009-09-04

Opinion for Merck & Company (MRK-N)

Signal Price Bias Subject Owned
COMMENT $30.700 OPTIMISTIC NORTH AMERICAN - LARGE Unknown

Pharmaceutical. More disciplined approach so they've been generating very strong free cash flow. A couple of their strong drugs will be coming off patent in a couple of years. In the process of merging with Schering-Plough (SGP-N). If you were going to pick a name, he would prefer Abbott (ABT-N). 5% dividend yield.

Andrew Guy, CFA
Portfolio Manager, Sentry Select Capital Corp. http://www.sentryselect.com/

No Comments.


You must be logged in to comment.